Astellas Pharma Inc. (ALPMF)

AI Score

Unlock

8.87

0.00 (0.00%)

At close: Apr 14, 2025, 1:01 PM

Astellas Pharma Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	335.69B	376.84B	315.99B	326.13B	318.39B	311.07B	331.73B	340.92B	360.03B
Short-Term Investments	28.78B	19.78B	21.3B	5.56B	9.46B	2.61B	13.52B	13.55B	14.39B
Long-Term Investments	163.02B	145.03B	141.21B	146.8B	123.15B	118.48B	57B	51.03B	77.47B
Other Long-Term Assets	45.59B	1M	-1M	-1M	-1M	-2M	47.17B	48.97B	53.27B
Receivables	534.99B	427.96B	382.46B	343.18B	347.04B	342.63B	319.51B	309.82B	327.6B
Inventory	248.74B	174.39B	153.07B	164.08B	151.02B	151.51B	147.63B	182.54B	161.69B
Other Current Assets	75.32B	70.76B	71.83B	39.2B	39.58B	39.2B	37.6B	32.63B	38B
Total Current Assets	1,194.7B	1,050B	923.35B	872.59B	867.51B	857.16B	845.62B	876.66B	897.54B
Property-Plant & Equipment	293.74B	286.46B	269.04B	264.62B	268.6B	173.48B	181.29B	191.12B	200.96B
Goodwill & Intangibles	1,872.5B	890.91B	926.46B	935.44B	1,006B	655.57B	629.89B	562.77B	489.86B
Total Long-Term Assets	2,374.9B	1,406.6B	1,409B	1,401B	1,450.6B	1,040.5B	1,012.6B	944.24B	901.8B
Total Assets	3,569.6B	2,456.5B	2,332.4B	2,273.6B	2,318.2B	1,897.6B	1,858.2B	1,820.9B	1,799.3B
Account Payables	185.19B	140.24B	130.74B	124.78B	171.95B	185.28B	140.91B	182.83B	181.56B
Deferred Revenue	n/a	-88.55B	-157.73B	-136.1B	11.7B	13.32B	60.03B	58.9B	28.78B
Short-Term Debt	472.28B	75B	n/a	120B	344.11B	n/a	n/a	n/a	n/a
Other Current Liabilities	458.08B	366.98B	420.12B	222.7B	194.67B	297.16B	154.9B	102.84B	145.7B
Total Current Liabilities	1,285.7B	726.03B	687.41B	592.37B	798.71B	497.67B	421.62B	399.86B	413.36B
Long-Term Debt	447.74B	50B	n/a	80.4B	3.14B	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	169.4B	51.25B	45.73B	50.94B	-15.57B	39.86B	146B	115.08B	126.77B
Total Long-Term Liabilities	687.89B	222.53B	184.68B	295.14B	230.28B	141.59B	168.3B	149.24B	126.77B
Total Liabilities	1,973.6B	948.56B	872.09B	887.51B	1,029B	639.25B	589.92B	549.09B	540.13B
Total Debt	1,005.7B	200.01B	212.74B	278.26B	413.33B	1.2B	1.35B	1.64B	1.23B
Common Stock	103B	103B	103B	103B	103B	103B	103B	103B	103B
Retained Earnings	809.4B	908.16B	944.26B	953.29B	905.85B	991.96B	976.08B	1,013.9B	973.05B
Comprehensive Income	n/a	340.64B	247.51B	167.37B	109.99B	150.77B	147.94B	116B	163.36B
Shareholders Equity	1,596B	1,508B	1,460.3B	1,386.1B	1,289.2B	1,258.4B	1,268.3B	1,271.8B	1,259.2B
Total Investments	124.38B	110.58B	101.88B	102.97B	78.96B	85.11B	70.51B	64.58B	91.86B